Published in Health Business Week, February 2nd, 2007
Relisys' new stent consists of a Cobalt-Chromium Stent, coated with a porous carbon/carbon composite nano-structured matrix with a surface design for improved endothelialization. Relisys' chairman N. Krishna Reddy said this version of a coronary stent has the potential to overcome certain concerns with current Drug-Eluting Stents substantially. Krishna Reddy pointed out that the animal study results at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.